{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "authorship_tag": "ABX9TyNIKn4sagYlSS0z+YJiJUQ7",
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/louisdennington-design/decision-tree-dissertation/blob/main/html_preprocessing.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 1,
      "metadata": {
        "id": "MUZWb8H2wEBt",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "de15589a-051a-4cc5-ece0-699a174006c6"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Mounted at /content/drive\n"
          ]
        }
      ],
      "source": [
        "# Mount Google Drive\n",
        "\n",
        "from google.colab import drive\n",
        "drive.mount('/content/drive')"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import re"
      ],
      "metadata": {
        "id": "QIsQGo2zwdAV"
      },
      "execution_count": 2,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Global parameters\n",
        "\n",
        "URL_abortion = 'https://www.nice.org.uk/guidance/ng140/chapter/Recommendations'\n",
        "URL_pneumonia = 'https://www.nice.org.uk/guidance/ng250/chapter/Recommendations'\n",
        "URL_bipolar = 'https://www.nice.org.uk/guidance/cg185/chapter/Recommendations'\n",
        "\n",
        "# regex indicating start of relevant text?\n",
        "# regex indicating end of relevant text?"
      ],
      "metadata": {
        "id": "7a9FwD40wgkp"
      },
      "execution_count": 4,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Needs incorporation into functions below or deletion?\n",
        "\n",
        "from dataclasses import dataclass\n",
        "\n",
        "@dataclass\n",
        "class recommendation_entity:\n",
        "    \"\"\"\n",
        "    Defines the format that text is stored in when scraped from the html\n",
        "    \"\"\"\n",
        "    recommendation_id: int\n",
        "    parent_heading: str\n",
        "    recommendation_text: str\n",
        "    recommendation_url: str # Sometimes a bullet point incorporates a hyperlink to refer to earlier guidance\n",
        "\n",
        "# If needing to force a finite list in one of the class fields\n",
        "\n",
        "from enum import Enum\n",
        "\n",
        "class types_of_thing(Enum):\n",
        "    \"\"\"\n",
        "    1. Adjust the name\n",
        "    2. Add it as a field, e.g., types_of_thing: types_of_thing\n",
        "    \"\"\"\n",
        "    THIS = \"this\"\n",
        "    THAT = \"that\"\n",
        "    OR_THIS = \"or_this\""
      ],
      "metadata": {
        "id": "dajmh1sAxG7e"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Scrape the text\n",
        "\n",
        "from bs4 import BeautifulSoup\n",
        "import requests\n",
        "\n",
        "url = URL_bipolar\n",
        "\n",
        "html_scrape = requests.get(url).text\n",
        "\n",
        "soup = BeautifulSoup(html_scrape, \"html.parser\")\n",
        "\n",
        "#print(soup.prettify())"
      ],
      "metadata": {
        "id": "-kudDQMndgVs"
      },
      "execution_count": 5,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Processing function\n",
        "\n",
        "\n",
        "# FIXES NEEDED\n",
        "## What is being labelled as 'sub_heading_2' should instead be 'recommendation_text' or similar\n",
        "## Headings before bullet points are being omitted and only the bullet points saved, e.g., \"Give carers written and verbal information in an accessible format about:\"\"\n",
        "## Sections 1.3 and 1.4 have been skipped, others too - Why?\n",
        "## Box on Valproate (<div class=\"panel panel--primary\">) should be included\n",
        "## Check how / whether headings of boxes (\"strong\") and some sub-sections (e.g., \"Starting antipsychotic medication\") are being ingested properly\n",
        "\n",
        "\"\"\"\n",
        "- begin at <div class=\"section\" title=\"1.1\n",
        "- end before \"Terms used in this guideline\"\n",
        "- store every <div class=\"recommendation__body\">\n",
        "- store the parent heading <h3 class=\"title\" id=\"\">, sub-heading (if exists) <h4 class=\"title\" id=\"\">, and sub-sub-heading <h5 class=\"title\" id=\"\"\n",
        "- collapse bullet points into recommendation:\n",
        "\n",
        "        <ul class=\"itemizedlist indented\">\n",
        "            <li class=\"listitem\">\n",
        "\n",
        "- exclude <div class=\"panel\">\n",
        "- save <div class=\"panel panel--primary\"> as separate text to be accessed later if needed\n",
        "- if link occurs within <div class=\"section\">, as <a class=\"link\" href=\"\", then extract the URL\n",
        "\n",
        "- if doing the Pneumonia guideline, will also need to think about how to digest <div class=\"informaltable\">\n",
        "\"\"\"\n",
        "\n",
        "def process_html(soup):\n",
        "\n",
        "    raw_guideline_data = []\n",
        "    current_heading = None\n",
        "    sub_heading_1 = None\n",
        "\n",
        "    start = soup.find(\"h3\", string = lambda s: s and s.strip().startswith(\"1.1\"))\n",
        "    if start is None:\n",
        "        print(\"Start point specified in function does not match page formatting.\")\n",
        "        return raw_guideline_data\n",
        "\n",
        "    current_heading = start.get_text(strip=True)\n",
        "\n",
        "    for element in start.next_elements:\n",
        "        if getattr(element, \"name\", None) is None:\n",
        "            continue # so that it only recognises tags, and not unnamed strings\n",
        "\n",
        "        classes = element.get(\"class\", [])\n",
        "\n",
        "        if element.name == \"h3\" and \"title\" in classes:\n",
        "            current_heading = element.get_text(strip=True)\n",
        "            sub_heading_1 = None\n",
        "\n",
        "        elif element.name == \"h4\" and \"title\" in classes:\n",
        "            sub_heading_1 = element.get_text(strip=True)\n",
        "\n",
        "        elif element.name == \"article\" and \"recommendation\" in classes:\n",
        "            number_tag = element.find(\"h5\", class_=\"recommendation__number\")\n",
        "            body_tag = element.find(\"div\", class_=\"recommendation__body\")\n",
        "\n",
        "            if not number_tag or not body_tag:\n",
        "                continue\n",
        "\n",
        "            sub_heading_2 = number_tag.get_text(strip=True)\n",
        "\n",
        "            bullet_points = []\n",
        "            for li in body_tag.find_all(\"li\"):\n",
        "                bullet_points.append(li.get_text(\" \", strip=True).replace(\"\\xa0\", \" \"))\n",
        "\n",
        "            if bullet_points:\n",
        "                recommendation_text = \", and \".join(bullet_points)\n",
        "            else:\n",
        "                recommendation_text = body_tag.get_text(\" \", strip=True)\n",
        "\n",
        "            recommendation_text = recommendation_text.replace(\"\\xa0\", \" \")\n",
        "\n",
        "            raw_guideline_data.append({\n",
        "                \"heading_1\": current_heading,\n",
        "                \"sub_heading_1\": sub_heading_1,\n",
        "                \"sub_heading_2\": sub_heading_2,\n",
        "                \"text\": recommendation_text})\n",
        "\n",
        "    return raw_guideline_data\n",
        "\n",
        "raw_guideline_data = process_html(soup)\n",
        "\n",
        "print(raw_guideline_data)"
      ],
      "metadata": {
        "id": "pneKMpDTxfwJ",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "c6d9d79c-2c2d-4646-af6b-b55f96a25780"
      },
      "execution_count": 6,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[{'heading_1': '1.1 Care for adults, children and young people across all phases of bipolar disorder', 'sub_heading_1': 'Treatment and support for specific populations', 'sub_heading_2': '1.1.1', 'text': 'Ensure that older people with bipolar disorder are offered the same range of treatments and services as younger people with bipolar disorder. [2014]'}, {'heading_1': '1.1 Care for adults, children and young people across all phases of bipolar disorder', 'sub_heading_1': 'Treatment and support for specific populations', 'sub_heading_2': '1.1.2', 'text': \"Offer people with bipolar disorder and coexisting disorders, such as personality disorder, attention deficit hyperactivity disorder, anxiety disorders or substance misuse, treatment in line with the relevant NICE guideline, in addition to their treatment for bipolar disorder. See NICE's guidelines on antisocial personality disorder , borderline personality disorder , attention deficit hyperactivity disorder , generalised anxiety disorder and panic disorder in adults and psychosis with coexisting substance misuse , be alert to the potential for drug interactions and use clinical judgement. [2014]\"}, {'heading_1': '1.1 Care for adults, children and young people across all phases of bipolar disorder', 'sub_heading_1': 'Treatment and support for specific populations', 'sub_heading_2': '1.1.3', 'text': 'Offer people with rapid cycling bipolar disorder the same interventions as people with other types of bipolar disorder because there is currently no strong evidence to suggest that people with rapid cycling bipolar disorder should be treated differently. [2014]'}, {'heading_1': '1.1 Care for adults, children and young people across all phases of bipolar disorder', 'sub_heading_1': 'Information and support', 'sub_heading_2': '1.1.4', 'text': 'Consider identifying and offering assistance with education, financial and employment problems that may result from the behaviour associated with bipolar disorder, such as mania and hypomania. If the person with bipolar disorder agrees, this could include talking directly with education staff, creditors and employers about bipolar disorder and its possible effects, and how the person can be supported. [2014]'}, {'heading_1': '1.1 Care for adults, children and young people across all phases of bipolar disorder', 'sub_heading_1': 'Information and support', 'sub_heading_2': '1.1.5', 'text': 'Explain and discuss making a lasting power of attorney with adults with bipolar disorder and their carers if there are financial problems resulting from mania or hypomania. [2014]'}, {'heading_1': '1.1 Care for adults, children and young people across all phases of bipolar disorder', 'sub_heading_1': 'Support for carers of people with bipolar disorder', 'sub_heading_2': '1.1.6', 'text': 'diagnosis and management of bipolar disorder, and positive outcomes and recovery, and types of support for carers, and role of teams and services, and getting help in a crisis. [2014]'}, {'heading_1': '1.1 Care for adults, children and young people across all phases of bipolar disorder', 'sub_heading_1': 'Support for carers of people with bipolar disorder', 'sub_heading_2': '1.1.7', 'text': \"As early as possible negotiate with the person with bipolar disorder and their carers about how information about the person will be shared. When discussing rights to confidentiality, emphasise the importance of sharing information about risks and the need for carers to understand the person's perspective. Foster a collaborative approach that supports both people with bipolar disorder and their carers, and respects their individual needs and interdependence. [2014]\"}, {'heading_1': '1.1 Care for adults, children and young people across all phases of bipolar disorder', 'sub_heading_1': 'Support for carers of people with bipolar disorder', 'sub_heading_2': '1.1.8', 'text': 'be available as needed, and have a positive message about recovery. [2014]'}, {'heading_1': '1.1 Care for adults, children and young people across all phases of bipolar disorder', 'sub_heading_1': 'Support for carers of people with bipolar disorder', 'sub_heading_2': '1.1.9', 'text': 'review the need for an assessment according to local safeguarding procedures for children or adults as appropriate, and offer psychological and social support as needed. [2014]'}, {'heading_1': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'sub_heading_1': 'Recognising bipolar disorder in primary care and referral', 'sub_heading_2': '1.2.1', 'text': 'When adults present in primary care with depression , ask about previous periods of overactivity or disinhibited behaviour. If the overactivity or disinhibited behaviour lasted for 4 days or more, consider referral for a specialist mental health assessment. [2014]'}, {'heading_1': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'sub_heading_1': 'Recognising bipolar disorder in primary care and referral', 'sub_heading_2': '1.2.2', 'text': 'Refer people urgently for a specialist mental health assessment if mania or severe depression is suspected or they are a danger to themselves or others. [2014]'}, {'heading_1': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'sub_heading_1': 'Recognising bipolar disorder in primary care and referral', 'sub_heading_2': '1.2.3', 'text': 'Do not use questionnaires in primary care to identify bipolar disorder in adults. [2014]'}, {'heading_1': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'sub_heading_1': 'Managing bipolar disorder in primary care', 'sub_heading_2': '1.2.4', 'text': 'support them to carry out care plans developed in secondary care and achieve their recovery goals, and follow crisis plans developed in secondary care and liaise with secondary care specialists if necessary, and review their treatment and care, including medication, at least annually and more often if the person, carer or healthcare professional has any concerns. [2014]'}, {'heading_1': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'sub_heading_1': 'Managing bipolar disorder in primary care', 'sub_heading_2': '1.2.5', 'text': 'a psychological intervention that has been developed specifically for bipolar disorder and has a published evidence-based manual describing how it should be delivered or, and a choice of psychological intervention (cognitive behavioural therapy, interpersonal therapy or behavioural couples therapy) in line with the advice on treatment options for more severe depression in the NICE guideline on depression . Discuss with the person the possible benefits and risks of psychological interventions and their preference. Monitor mood and if there are signs of hypomania or deterioration of the depressive symptoms, liaise with or refer the person to secondary care. If the person develops mania or severe depression, refer them urgently to secondary care. [2014]'}, {'heading_1': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'sub_heading_1': 'Managing bipolar disorder in primary care', 'sub_heading_2': '1.2.6', 'text': 'Psychological therapists working with people with bipolar depression in primary care should have training in and experience of working with people with bipolar disorder. [2014]'}, {'heading_1': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'sub_heading_1': 'Managing bipolar disorder in primary care', 'sub_heading_2': '1.2.7', 'text': 'Do not start lithium to treat bipolar disorder in primary care for people who have not taken lithium before, except under shared‑care arrangements. [2014]'}, {'heading_1': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'sub_heading_1': 'Managing bipolar disorder in primary care', 'sub_heading_2': '1.2.8', 'text': 'Do not start valproate in primary care to treat bipolar disorder. [2014]'}, {'heading_1': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'sub_heading_1': 'Managing bipolar disorder in primary care', 'sub_heading_2': '1.2.9', 'text': \"there is a poor or partial response to treatment, and the person's functioning declines significantly, and treatment adherence is poor, and the person develops intolerable or medically important side effects from medication, and comorbid alcohol or drug misuse is suspected, and the person is considering stopping any medication after a period of relatively stable mood, and a woman with bipolar disorder is pregnant or planning a pregnancy. [2014]\"}, {'heading_1': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'sub_heading_1': 'Physical health', 'sub_heading_2': '1.2.10', 'text': 'Develop and use practice case registers to monitor the physical and mental health of people with bipolar disorder in primary care. [2014]'}, {'heading_1': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'sub_heading_1': 'Physical health', 'sub_heading_2': '1.2.11', 'text': 'Monitor the physical health of people with bipolar disorder when responsibility for monitoring is transferred from secondary care, and then at least annually. The health check should be comprehensive, including all the checks recommended in recommendation 1.2.12 and focusing on physical health problems such as cardiovascular disease, diabetes, obesity and respiratory disease. A copy of the results should be sent to the care coordinator and psychiatrist, and put in the secondary care records. [2014]'}, {'heading_1': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'sub_heading_1': 'Physical health', 'sub_heading_2': '1.2.12', 'text': 'weight or BMI, diet, nutritional status and level of physical activity, and cardiovascular status, including pulse and blood pressure, and metabolic status, including fasting blood glucose or glycosylated haemoglobin (HbA1c), and blood lipid profile, and liver function, and renal and thyroid function, and calcium levels, for people taking long‑term lithium. [2014, amended 2021]'}, {'heading_1': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'sub_heading_1': 'Physical health', 'sub_heading_2': '1.2.13', 'text': \"Identify people with bipolar disorder who have hypertension, have abnormal lipid levels, are obese or at risk of obesity, have diabetes or are at risk of diabetes (as indicated by abnormal blood glucose levels), or are physically inactive, at the earliest opportunity. Follow NICE's guidelines on hypertension , cardiovascular disease: risk assessment and reduction, including lipid modification , prevention of cardiovascular disease , overweight and obesity management , physical activity and preventing type 2 diabetes . [2014]\"}, {'heading_1': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'sub_heading_1': 'Physical health', 'sub_heading_2': '1.2.14', 'text': \"Offer treatment to people with bipolar disorder who have diabetes and/or cardiovascular disease in primary care in line with NICE's guidelines on type 1 diabetes in adults: diagnosis and management , type 2 diabetes in adults: management and cardiovascular disease: risk assessment and reduction, including lipid modification . [2014]\"}, {'heading_1': '1.5 Managing mania or hypomania in adults in secondary care', 'sub_heading_1': 'Support and advice', 'sub_heading_2': '1.5.1', 'text': 'Ensure that people with mania or hypomania have access to calming environments and reduced stimulation. Advise them not to make important decisions until they have recovered from mania or hypomania and encourage them to maintain their relationships with their carers if possible. [2014]'}, {'heading_1': '1.5 Managing mania or hypomania in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.5.2', 'text': 'consider stopping the antidepressant and, and offer an antipsychotic as set out in recommendation 1.5.3, regardless of whether the antidepressant is stopped. [2014]'}, {'heading_1': '1.5 Managing mania or hypomania in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.5.3', 'text': \"If a person develops mania or hypomania and is not taking an antipsychotic or mood stabiliser, offer haloperidol, olanzapine, quetiapine or risperidone, taking into account any advance statements, the person's preference and clinical context (including physical comorbidity, previous response to treatment and side effects). Follow the recommendations on using antipsychotics in the section on how to use medication . [2014]\"}, {'heading_1': '1.5 Managing mania or hypomania in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.5.4', 'text': \"If the first antipsychotic is poorly tolerated at any dose (including rapid weight gain) or ineffective at the maximum licensed dose, offer an alternative antipsychotic from the drugs listed in recommendation 1.5.3, taking into account any advance statements, the person's preference and clinical context (including physical comorbidity, previous response to treatment and side effects). [2014]\"}, {'heading_1': '1.5 Managing mania or hypomania in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.5.5', 'text': \"If an alternative antipsychotic is not sufficiently effective at the maximum licensed dose, consider adding lithium. Although its use is common in UK clinical practice, in September 2014 this was an off-label use of lithium. See NICE's information on prescribing medicines . [2014, amended 2023]\"}, {'heading_1': '1.5 Managing mania or hypomania in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.5.6', 'text': \"If adding lithium is ineffective, or if lithium is not suitable (for example, because the person does not agree to routine blood monitoring), consider adding valproate instead. Follow the MHRA safety measures and precautionary advice for valproate in box 1 . [2014] In September 2025 semi-sodium valproate had a UK marketing authorisation for the treatment of mania if lithium is not tolerated or is contraindicated; use of other formulations of valproate would be off-label, although use is common in UK clinical practice. See NICE's information on prescribing medicines .\"}, {'heading_1': '1.5 Managing mania or hypomania in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.5.7', 'text': 'If a person develops mania or hypomania and is taking an antidepressant (as defined by the BNF ) in combination with a mood stabiliser, consider stopping the antidepressant. [2014]'}, {'heading_1': '1.5 Managing mania or hypomania in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.5.8', 'text': \"If the person is already taking lithium, check plasma lithium levels to optimise treatment (see the section on how to use medication ). Consider adding haloperidol, olanzapine, quetiapine or risperidone, depending on the person's preference and previous response to treatment. [2014]\"}, {'heading_1': '1.5 Managing mania or hypomania in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.5.9', 'text': \"If the person is already taking a mood stabiliser as prophylactic treatment, consider increasing the dose, up to the maximum level in the BNF if necessary, depending on clinical response. If there is no improvement, consider adding haloperidol, olanzapine, quetiapine or risperidone, depending on the person's preference and previous response to treatment. Follow the recommendations on using antipsychotics in the section on how to use medication . [2014]\"}, {'heading_1': '1.5 Managing mania or hypomania in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.5.10', 'text': 'consider increasing the dose if tolerated, but be aware of the increased risk of side effects at higher doses, or, and consider changing to an alternative treatment. Follow the recommendations on using valproate in the section on how to use medication . [2014, amended 2023]'}, {'heading_1': '1.5 Managing mania or hypomania in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.5.11', 'text': 'If the clinical presentation is of a mixed affective state, characterised by both manic and depressive symptoms, follow recommendations 1.5.1 to 1.5.10 for the treatment of mania, and monitor closely for the emergence of depression. [2014]'}, {'heading_1': '1.5 Managing mania or hypomania in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.5.12', 'text': 'Do not offer lamotrigine to treat mania. [2014]'}, {'heading_1': '1.5 Managing mania or hypomania in adults in secondary care', 'sub_heading_1': 'Electroconvulsive therapy', 'sub_heading_2': '1.5.13', 'text': 'Electroconvulsive therapy (ECT) is recommended as an option in NICE technology appraisal guidance for rapid short-term treatment of a prolonged or severe manic episode when other treatments have not worked or the condition is life-threatening. For full details, see the guidance on the use of electroconvulsive therapy (TA59, 2009) .'}, {'heading_1': '1.5 Managing mania or hypomania in adults in secondary care', 'sub_heading_1': 'Reviewing treatment for mania', 'sub_heading_2': '1.5.14', 'text': 'Within 4 weeks of resolution of symptoms, discuss with the person, and their carers if appropriate, whether to continue treatment for mania or start long‑term treatment (see the section on managing bipolar disorder in adults in the longer term in secondary care ). Explain the potential benefits of long‑term treatment and the risks, including side effects of medication used for long‑term treatment. [2014]'}, {'heading_1': '1.5 Managing mania or hypomania in adults in secondary care', 'sub_heading_1': 'Reviewing treatment for mania', 'sub_heading_2': '1.5.15', 'text': 'If the person decides to continue treatment for mania, offer it for a further 3 to 6 months, and then review. [2014]'}, {'heading_1': '1.6 Managing bipolar depression in adults in secondary care', 'sub_heading_1': 'Psychological interventions', 'sub_heading_2': '1.6.1', 'text': 'a psychological intervention that has been developed specifically for bipolar disorder and has a published evidence-based manual describing how it should be delivered or, and a choice of psychological intervention (cognitive behavioural therapy, interpersonal therapy or behavioural couples therapy) in line with the advice on treatment options for more severe depression in the NICE guideline on depression . Discuss with the person the possible benefits and risks of psychological interventions and their preference. Monitor mood for signs of mania or hypomania or deterioration of the depressive symptoms. [2014]'}, {'heading_1': '1.6 Managing bipolar depression in adults in secondary care', 'sub_heading_1': 'Psychological interventions', 'sub_heading_2': '1.6.2', 'text': 'Psychological therapists working with people with bipolar depression should have training in, and experience of, working with people with bipolar disorder. [2014]'}, {'heading_1': '1.6 Managing bipolar depression in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.6.3', 'text': \"If the person prefers, consider either olanzapine (without fluoxetine) or lamotrigine on its own., and If there is no response to fluoxetine combined with olanzapine, or quetiapine, consider lamotrigine on its own. Follow the recommendations on using antipsychotics and lamotrigine in the section on how to use medication . In September 2014, this was an off-label use of olanzapine. Although their use was common in UK clinical practice, in September 2014 this was an off-label use of fluoxetine and of lamotrigine. See NICE's information on prescribing medicines . [2014]\"}, {'heading_1': '1.6 Managing bipolar depression in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.6.4', 'text': \"If the person prefers, consider adding olanzapine (without fluoxetine) or lamotrigine to lithium., and If there is no response to adding fluoxetine combined with olanzapine, or adding quetiapine, stop the additional treatment and consider adding lamotrigine to lithium. Follow the recommendations in the section on how to use medication on using lithium, antipsychotics and lamotrigine . In September 2014, these were off-label uses of olanzapine, risperidone, haloperidol, quetiapine, lamotrigine and lithium for children and young people. See NICE's information on prescribing medicines . [2014]\"}, {'heading_1': '1.6 Managing bipolar depression in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.6.5', 'text': 'If a person develops moderate or severe bipolar depression and is already taking valproate , review their treatment including adherence and consider increasing the dose if tolerated but be aware of the increased risk of side effects at higher doses. Follow the recommendations on using valproate in the section on how to use medication . [2014, amended 2023]'}, {'heading_1': '1.6 Managing bipolar depression in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.6.6', 'text': \"fluoxetine combined with olanzapine or, and quetiapine. Follow the recommendations on using valproate and antipsychotics in the section on how to use medication . In September 2014, these were off-label uses of olanzapine, quetiapine and valproate for children and young people. See NICE's information on prescribing medicines . [2014, amended 2023]\"}, {'heading_1': '1.6 Managing bipolar depression in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.6.7', 'text': \"adding olanzapine (without fluoxetine) or, and adding lamotrigine or, and changing from valproate to an alternative treatment. Follow the recommendations on using valproate, antipsychotics and lamotrigine in the section on how to use medication . In September 2014, these were off-label uses of olanzapine, quetiapine, lamotrigine and valproate for children and young people. See NICE's information on prescribing medicines . [2014, amended 2023]\"}, {'heading_1': '1.6 Managing bipolar depression in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.6.8', 'text': \"adding lamotrigine to valproate or, and changing from valproate to an alternative treatment. Follow the recommendations on using valproate, antipsychotics and lamotrigine in the section on how to use medication . In September 2014, these were off-label uses of olanzapine, quetiapine, lamotrigine and valproate for children and young people. See NICE's information on prescribing medicines . [2014, amended 2023]\"}, {'heading_1': '1.6 Managing bipolar depression in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.6.9', 'text': 'Follow the recommendations on using antipsychotics in the section on how to use medication and be aware of the potential interactions between valproate and fluoxetine, lamotrigine and olanzapine. Follow the MHRA safety measures and precautionary advice for valproate in box 1 . [2014, amended 2020]'}, {'heading_1': '1.6 Managing bipolar depression in adults in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.6.10', 'text': 'Take into account toxicity in overdose when prescribing psychotropic medication during periods of high suicide risk. Assess the need to limit the quantity of medication supplied to reduce the risk to life if the person overdoses. [2014]'}, {'heading_1': '1.6 Managing bipolar depression in adults in secondary care', 'sub_heading_1': 'Reviewing treatment for bipolar depression', 'sub_heading_2': '1.6.11', 'text': 'Within 4 weeks of resolution of symptoms, discuss with the person, and their carers if appropriate, whether to continue psychological or pharmacological treatment for bipolar depression or start long‑term treatment (see the section on managing bipolar disorder in adults in the longer term in secondary care ). Explain the potential benefits of long‑term treatment and the risks, including side effects of medication used for long‑term treatment. [2014]'}, {'heading_1': '1.6 Managing bipolar depression in adults in secondary care', 'sub_heading_1': 'Reviewing treatment for bipolar depression', 'sub_heading_2': '1.6.12', 'text': 'If the person decides to continue psychological or pharmacological treatment for bipolar depression, offer it for a further 3 to 6 months, and then review. [2014]'}, {'heading_1': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'sub_heading_1': 'Discussing long‑term treatment', 'sub_heading_2': '1.7.1', 'text': \"the nature and variable course of bipolar disorder, and the role of psychological and pharmacological interventions to prevent relapse and reduce symptoms, and the risk of relapse after reducing or stopping medication for an acute episode, and the potential benefits and risks of long‑term medication and psychological interventions, and the need to monitor mood and medication, and the potential benefits and risks of stopping medication, including for women who may wish to become pregnant, and the person's history of bipolar disorder, including: the severity and frequency of episodes of mania or bipolar depression, with a focus on associated risks and adverse consequences previous response to treatment symptoms between episodes potential triggers for relapse, early warning signs, and self‑management strategies, and the severity and frequency of episodes of mania or bipolar depression, with a focus on associated risks and adverse consequences, and previous response to treatment, and symptoms between episodes, and potential triggers for relapse, early warning signs, and self‑management strategies, and possible duration of treatment, and when and how often this should be reviewed. Provide clear written information about bipolar disorder, including NICE's information for the public , and ensure there is enough time to discuss options and concerns. [2014]\"}, {'heading_1': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'sub_heading_1': 'Psychological interventions', 'sub_heading_2': '1.7.2', 'text': \"Offer a family intervention to people with bipolar disorder who are living, or in close contact, with their family in line with recommendation 1.3.7.2 in NICE's guideline on psychosis and schizophrenia in adults . [2014]\"}, {'heading_1': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'sub_heading_1': 'Psychological interventions', 'sub_heading_2': '1.7.3', 'text': 'Offer a structured psychological intervention (individual, group or family), which has been designed for bipolar disorder and has a published evidence-based manual describing how it should be delivered, to prevent relapse or for people who have some persisting symptoms between episodes of mania or bipolar depression. [2014]'}, {'heading_1': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'sub_heading_1': 'Psychological interventions', 'sub_heading_2': '1.7.4', 'text': \"provide information about bipolar disorder, and consider the impact of thoughts and behaviour on moods and relapse, and include self‑monitoring of mood, thoughts and behaviour, and address relapse risk, distress and how to improve functioning, and develop plans for relapse management and staying well, and consider problem‑solving to address communication patterns and managing functional difficulties. In addition:, and individual programmes should be tailored to the person's needs based on an individualised assessment and psychological formulation, and group programmes should include discussion of the information provided with a focus on its relevance for the participants. [2014]\"}, {'heading_1': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.7.5', 'text': 'When planning long‑term pharmacological treatment to prevent relapse, take into account drugs that have been effective during episodes of mania or bipolar depression. Discuss with the person whether they prefer to continue this treatment or switch to lithium, and explain that lithium is the most effective long‑term treatment for bipolar disorder. [2014]'}, {'heading_1': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.7.6', 'text': 'When considering long-term treatment, discuss with the person the possible benefits and risks of each drug for them, following the recommendations in the section on how to use medication . [2014, amended 2023]'}, {'heading_1': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.7.7', 'text': 'Offer lithium as a first‑line, long‑term pharmacological treatment for bipolar disorder. [2014]'}, {'heading_1': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.7.8', 'text': 'If lithium is ineffective, poorly tolerated, or is not suitable (for example, because the person does not agree to routine blood monitoring), consider an antipsychotic (for example, asenapine, aripiprazole, olanzapine, quetiapine or risperidone). [2014, amended 2023]'}, {'heading_1': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.7.9', 'text': 'If the first antipsychotic is poorly tolerated at any dose (including rapid weight gain) or ineffective at the maximum licensed dose, consider an alternative antipsychotic from the drugs listed in recommendation 1.7.8. [2014, amended 2023]'}, {'heading_1': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.7.10', 'text': \"an antipsychotic or, and lithium. [2014] In September 2025 semi-sodium valproate had a UK marketing authorisation for this indication in people who have had mania that has responded to treatment with semi-sodium valproate; use of other formulations of valproate would be off-label, although use is common in UK clinical practice. See NICE's information on prescribing medicines .\"}, {'heading_1': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.7.11', 'text': 'discuss with the person how to recognise early signs of relapse and what to do if symptoms recur, and stop treatment gradually (see the section on how to use medication ) and monitor the person for signs of relapse. [2014]'}, {'heading_1': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'sub_heading_1': 'Pharmacological interventions', 'sub_heading_2': '1.7.12', 'text': 'Continue monitoring symptoms, mood and mental state for 2 years after medication has stopped entirely. This may be undertaken in primary care (see recommendation 1.9.3 ). [2014]'}, {'heading_1': '1.9 Promoting recovery and return to primary care', 'sub_heading_1': 'Continuing treatment in secondary care', 'sub_heading_2': '1.9.1', 'text': 'Continue treatment and care in an early intervention in psychosis service, a specialist bipolar disorder service or a specialist integrated community‑based team. Share physical health monitoring with primary care as outlined in the sections on physical health and monitoring physical health in primary care . [2014]'}, {'heading_1': '1.9 Promoting recovery and return to primary care', 'sub_heading_1': 'Continuing treatment in secondary care', 'sub_heading_2': '1.9.2', 'text': 'Consider intensive case management for people with bipolar disorder who are likely to disengage from treatment or services. [2014]'}, {'heading_1': '1.9 Promoting recovery and return to primary care', 'sub_heading_1': 'Return to primary care', 'sub_heading_2': '1.9.3', 'text': 'Offer people with bipolar disorder whose symptoms have responded effectively to treatment and remain stable the option to return to primary care for further management. If they wish to do this, record it in their notes and coordinate transfer of responsibilities through the care programme approach. [2014]'}, {'heading_1': '1.9 Promoting recovery and return to primary care', 'sub_heading_1': 'Return to primary care', 'sub_heading_2': '1.9.4', 'text': \"clear, individualised social and emotional recovery goals, and a crisis plan indicating early warning symptoms and triggers of both mania and depression relapse and preferred response during relapse, including liaison and referral pathways, and an assessment of the person's mental state, and a medication plan with a date for review by primary care, frequency and nature of monitoring for effectiveness and adverse effects, and what should happen in the event of a relapse. Give the person and their GP a copy of the plan, and encourage the person to share it with their carers . [2014]\"}, {'heading_1': '1.9 Promoting recovery and return to primary care', 'sub_heading_1': 'Return to primary care', 'sub_heading_2': '1.9.5', 'text': 'Encourage and support the person to visit their GP and discuss the care plan before discharge and transfer. [2014]'}, {'heading_1': '1.9 Promoting recovery and return to primary care', 'sub_heading_1': 'Employment, education and occupational activities', 'sub_heading_2': '1.9.6', 'text': 'Offer supported employment programmes to people with bipolar disorder in primary or secondary care who wish to find or return to work. Consider other occupational or educational activities, including pre‑vocational training, for people who are unable to work or unsuccessful in finding employment. [2014]'}, {'heading_1': '1.10 How to use medication', 'sub_heading_1': 'Using valproate', 'sub_heading_2': '1.10.27', 'text': 'If a woman or girl of childbearing potential is already taking valproate, advise her to gradually stop the drug under medical supervision because of the risk of fetal malformations and adverse neurodevelopmental outcomes after any exposure in pregnancy . Follow the MHRA safety measures and precautionary advice for valproate in box 1 . [2014, amended 2020]'}, {'heading_1': '1.10 How to use medication', 'sub_heading_1': 'Using valproate', 'sub_heading_2': '1.10.28', 'text': 'Be aware that there is a possible association between valproate use in men around the time of conception and an increased risk of neurodevelopmental disorders in their children. Follow the MHRA safety measures and precautionary advice for valproate in box 1 . [2025]'}, {'heading_1': '1.11 Recognising, diagnosing and managing bipolar disorder in children and young people', 'sub_heading_1': 'Recognition and referral', 'sub_heading_2': '1.11.1', 'text': 'Do not use questionnaires in primary care to identify bipolar disorder in children or young people. [2014]'}, {'heading_1': '1.11 Recognising, diagnosing and managing bipolar disorder in children and young people', 'sub_heading_1': 'Recognition and referral', 'sub_heading_2': '1.11.2', 'text': 'If bipolar disorder is suspected in primary care in children or young people aged under 14 years, refer them to child and adolescent mental health services (CAMHS). [2014]'}, {'heading_1': '1.11 Recognising, diagnosing and managing bipolar disorder in children and young people', 'sub_heading_1': 'Recognition and referral', 'sub_heading_2': '1.11.3', 'text': 'engagement or assertive outreach approaches, and family involvement and family intervention, and access to structured psychological interventions and psychologically informed care, and vocational and educational interventions, and access to pharmacological interventions, and professionals who are trained and competent in working with young people with bipolar disorder. [2014]'}, {'heading_1': '1.11 Recognising, diagnosing and managing bipolar disorder in children and young people', 'sub_heading_1': 'Management in young people', 'sub_heading_2': '1.11.8', 'text': 'When offering treatment to young people with bipolar disorder, take into account their cognitive ability, emotional maturity, developmental level, their capacity to consent to treatment, the severity of their bipolar disorder and risk of suicide or self‑harm or any other risk outlined in recommendation 1.3.5 . [2014]'}]\n"
          ]
        }
      ]
    }
  ]
}